Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.
Feb 14 15:24 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lang Matthew
Feb 13 20:31 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.
Feb 13 20:26 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.
Feb 13 20:26 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Newton Charles W.
Feb 13 20:21 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn
Feb 13 20:21 ET
Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.40%)
Feb 13 17:52 ET
Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.7%)
Jan 29 17:37 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Newton Charles W.
Nov 20, 2023 20:55 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Lee Gary K.
Nov 20, 2023 20:54 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Seely Lynn
Nov 20, 2023 20:53 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Officer Hill Stephen J.
Nov 20, 2023 20:52 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard
Sep 8, 2023 16:30 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL
Sep 8, 2023 16:27 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY
Sep 8, 2023 16:26 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT
Sep 8, 2023 16:24 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NABEL ELIZABETH G
Sep 8, 2023 16:23 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W
Sep 8, 2023 16:22 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar
Sep 8, 2023 16:20 ET
Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard
Aug 17, 2023 16:23 ET
No Data
No Data